Experienced leader with track record of program ownership and strategy execution. Versed with all aspects of developing novel and repurposed medicines including vaccines, biosimilars, cell-based therapies, and anti-infectives. Managed large, interdisciplinary project teams, built best-in-class operations, and brought new therapies to patients. Multiple strategy execution, program management and subject-matter-expert roles with top tier biopharma companies. Highly energized by challenging roles in translating science to the clinic, advancing clinical pipelines and managing strategic alliances.